We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Automated Liquid Handling Platforms to Expand Use of 3D Cell Culture

By LabMedica International staff writers
Posted on 19 Nov 2012
Print article
Image: The TAP RAFT 3D cell culturing system (Photo courtesy of TAP Biosystems).
Image: The TAP RAFT 3D cell culturing system (Photo courtesy of TAP Biosystems).
Two state-of-the-art biotech companies have announced a comarketing agreement to expand the use of three-dimensional (3D) cell culture techniques through adaptation to automated liquid handling platforms.

TAP Biosystems (Cambridge, United Kingdom) will be collaborating with Tecan (Männedorf, Switzerland) to automate the TAP RAFT (Real Architecture for 3D Tissue) 3D cell culturing system for use with the Tecan Freedom EVO liquid handling platform.

The Tecan Freedom EVO series offers worktables with building-block modularity that ensures precision, reliable liquid handling, and easy-to-use robotics. Each platform can be combined with a wide choice of robotic arms, liquid handling tools, and application options powered by straightforward software that can be programmed to meet the needs of each individual laboratory.

The RAFT 3D cell culture system uses biologically relevant concentrations of collagen matrix to ensure cells grow and proliferate in an environment closely resembling the native tissue. By combining RAFT with the Freedom EVO to automate the preparation of the collagen matrix plus media and reagent additions, researchers will have access to a rapid, reliable process for creation of consistent and reproducible 3D cell cultures.

The RAFT system requires only three simple steps to establish 96-well cell cultures. Cells and neutralized collagen are mixed, dispensed into a 96-well culture plate and incubated to create cell-seeded hydrogels. The RAFT plate gently removes medium from the hydrogels to create 96 in vivo collagen cell cultures, which may be analyzed using a broad range of biochemical, immunological, or imaging techniques.

Kevin Moore, head of applications and solutions at Tecan, said, “We are pleased to further expand our automated 3D cell culture portfolio to include the RAFT system. Working together with TAP Biosystems, we will be able to offer a complete solution for automated 3D cell culture.”

Dr. Grant Cameron, RAFT development director at TAP Biosystems, said, “RAFT is rapidly becoming a core secondary screening technology within drug discovery. This exciting collaboration will enable researchers to expand the power of the realistic collagen environment of RAFT, with substantially increased throughput to meet their cell-based screening requirements.”

Related Links:
TAP Biosystems
Tecan


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.